Atsuhiro Ichihara
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulness of the direct renin inhibitor aliskiren.
Journal: Journal of pharmacological sciences
Published: August 03, 2010
Possible roles of human (pro)renin receptor suggested by recent clinical and experimental findings.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: December 19, 2009
Renin, prorenin and the kidney: a new chapter in an old saga.
Journal: Journal of nephrology
Published: June 27, 2009
Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
Journal: Journal of pharmacological sciences
Published: January 20, 2009
Activated prorenin as a therapeutic target for diabetic nephropathy.
Journal: Diabetes research and clinical practice
Published: October 17, 2008
Involvement of (pro)renin receptor in the glomerular filtration barrier.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 11, 2008
Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: December 03, 2007
Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
Journal: Journal of cardiovascular pharmacology
Published: April 07, 2007
Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 04, 2006
Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
Journal: Journal of human hypertension
Published: July 01, 2006
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Journal: Journal of the American Society of Nephrology : JASN
Published: June 02, 2006
Last Updated: 09/26/2026